Cardiff Oncology, Inc. short interest in 2020
In 2020, Cardiff Oncology, Inc.'s disclosed short interest ran from 8.11% of shares outstanding on 15 Jul 2020 to 13.31% on 31 Dec 2020, a change of +5.20 percentage points. The year's high was 13.31% on 31 Dec 2020 and its low 2.91% on 14 Aug 2020, averaging 6.15% across 10 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 3.65 days on 31 Dec 2020. Full history: Cardiff Oncology, Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2020 in figures
- Start of year
- 8.11% (15 Jul 2020)
- End of year
- 13.31% (31 Dec 2020)
- Change
- +5.20 pp
- High
- 13.31% (31 Dec 2020)
- Low
- 2.91% (14 Aug 2020)
- Average
- 6.15%
- Highest days to cover
- 3.65 (31 Dec 2020)
- SEC filings marked
- 8
Every report in 2020
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jul 2020 | 8.11% | 1.52 | 10-K filed, results (8-K), 10-Q filed, results (8-K) |
| 31 Jul 2020 | 3.63% | 1.23 | |
| 14 Aug 2020 | 2.91% | 1.00 | 10-Q filed, results (8-K) |
| 31 Aug 2020 | 4.18% | 1.37 | |
| 15 Sep 2020 | 4.10% | 1.40 | |
| 30 Oct 2020 | 6.55% | 2.95 | |
| 13 Nov 2020 | 7.11% | 3.33 | 10-Q filed, results (8-K) |
| 30 Nov 2020 | 5.89% | 2.81 | |
| 15 Dec 2020 | 5.67% | 2.07 | |
| 31 Dec 2020 | 13.31% | 3.65 |
See also: Cardiff Oncology, Inc.'s full history · most shorted US stocks of 2020 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.